Acorai

Acorai has developed the first non-invasive Intracardiac Pressure Monitoring device, enabling cost-efficient heart failure care.

  • Stage Prototype Ready
  • Industry Medical Devices and Equipment
  • Location Palo Alto, CA, US
  • Currency USD
  • Founded August 2019
  • Employees 15
  • Incorporation Type Other
  • Website acorai.com

Company Summary

Acorai is a MedTech company, with a presence in the US (on-going, Q1 2023), Sweden and the UK. The business model is B2B, with the device being sold as an annual subscription. Acorai's product is the Acorai Heart Monitor, a non-invasive Intracardiac Pressure Monitoring device. With performance equivalent to the invasive clinical gold standard, the product is a first-of-its-kind device with unparalleled scalability and unit economics.

Team

  • Dan Vikström
    Finance Assistant

    Responsibilities: Accounting assistance, finance, financial research, administration of back-end data room and social media admin.

    Dan has 3 years experience in healthcare consumables for regions and municipalities in Sweden. He has a background in Accounting, Finance and Philosophy (Political Philosophy).

  • Filip Peters
    CEO & Co-founder

    Filip has 6+ years of experience managing engineering teams, planning, and executing research & development projects within the MedTech and finance industries across multiple countries. Filip has extensive experience in developing machine learning models. As CEO, Filip is responsible for the overall operations of Acorai. He has a background in machine learning development within finance and experience from working with three MedTech startups.

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free